Jonathan Birchall - Chief Commercial Officer at PhaseBio Pharmaceuticals Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Commercial Officer
Issuer Symbol
PHASQ
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Jonathan Birchall since 10 Jan 2025

Holdings reported by Jonathan Birchall for PhaseBio Pharmaceuticals Inc

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Employee Stock Option (right to buy) 52,500 24 Feb 2022 Direct Common Stock
Common Stock 20,000 20 May 2022 Direct
Restricted Stock Unit 11,250 24 Feb 2022 Direct Common Stock

Transactions reported by Jonathan Birchall for PhaseBio Pharmaceuticals Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.